for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Ambu A/S

AMBUb.CO

Latest Trade

114.45DKK

Change

-1.30(-1.12%)

Volume

1,187,965

Today's Range

112.65

 - 

115.80

52 Week Range

85.30

 - 

203.70

As of on the Copenhagen Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
115.75
Open
115.15
Volume
1,187,965
3M AVG Volume
26.41
Today's High
115.80
Today's Low
112.65
52 Week High
203.70
52 Week Low
85.30
Shares Out (MIL)
245.04
Market Cap (MIL)
25,174.42
Forward P/E
88.70
Dividend (Yield %)
0.35

Next Event

Q4 2019 Ambu A/S Earnings Release

Latest Developments

More

Ambu Q3 EBIT Before Special Items Rises To DKK 155 Mln

Ambu Says FY Financial Guidance Revised

Ambu A/S Is Expanding Its Product Portfolio And Commercial Infrastructure

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Ambu A/S

Ambu A/S is a Denmark-based company engaged in the development, manufacture and marketing of diagnostic and life-supporting devices for hospitals and rescue services. The Company’s operations are structured into three business areas: Anaesthesia, Patient Monitoring & Diagnostics and Emergency Care. The Anaesthesia business area offers a range of products from resuscitators, face masks and laryngeal masks to the single use flexible intubation scope. The Patient Monitoring & Diagnostics business area comprises single use electrodes for cardiological and neurological examinations. The target groups for these products are hospitals, clinics, ambulance services and sleep labs. The Emergency Care business area offers ventilation bags, neck collars and manikins for first-aid training. The Company markets its products worldwide. The Company operates King Systems Inc, First Water Heathcote Ltd and Invendo Medical GmbH as subsidiaries.

Industry

Medical Equipment & Supplies

Contact Info

Baltorpbakken 13

+45.72.252000

https://www.ambu.com/corp/home.aspx

Executive Leadership

Jens Bager

Independent Chairman of the Board

Juan-Jose Gonzalez

Chief Executive Officer

Mikael Worning

Independent Vice Chairman of the Board

Michael Hoejgaard

Executive Vice President, Global Finance, IT and Investor Relations, Chief Financial Officer, Member of the Executive Board

Henrik Ankjaer

Executive Vice President, Global Operations

Key Stats

2.67 mean rating - 6 analysts
Sell
Hold
Buy
Revenue (MM, DKK)

2016

2.1K

2017

2.4K

2018

2.6K

2019(E)

2.8K
EPS (DKK)

2016

1.054

2017

1.238

2018

1.360

2019(E)

1.245
Price To Earnings (TTM)
55.44
Price To Sales (TTM)
8.55
Price To Book (MRQ)
12.74
Price To Cash Flow (TTM)
39.77
Total Debt To Equity (MRQ)
51.12
LT Debt To Equity (MRQ)
50.54
Return on Investment (TTM)
14.02
Return on Equity (TTM)
12.25

Latest News

Medical device maker Ambu's shares dive after new CEO cuts outlook

Shares in Danish medical device maker Ambu plunged 18% in early trade on Tuesday after its new chief executive announced cuts to the company's growth prospects for this year and next.

UPDATE 1-Danish medical device maker Ambu sinks on CEO departure

Lars Marcher, CEO of Danish medical device maker Ambu, who has presided over a roughly 5,000 percent rise in the company's shares since 2008, is to step down and be replaced by a former Johnson & Johnson executive.

Danish medical equipment maker Ambu sinks after departure of CEO

Shares in Danish medical device maker Ambu slumped more than 10 percent on Friday after it surprisingly replaced its chief executive with a new boss hired from Johnson & Johnson.

BRIEF-Ambu Q2 2017/18 EBIT Rises To DKK 156 Million

* REG-AMBU A/S: INTERIM REPORT FOR Q2 2017/18 AND FOR THE HALF-YEAR (1 OCTOBER 2017- 31 MARCH 2018)

BRIEF-Ambu: Completion Of Share Buyback Programme

* IN TOTAL, DURING THE SHARE BUYBACK PROGRAMME AMBU BOUGHT 3,850,000 SHARES Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Ambu Q1 EBIT up at DKK 91 MLN

* OUR OUTLOOK ON EARNINGS AND FREE CASH FLOWS FOR YEAR ARE RAISED.

BRIEF-Ambu Reduces Nominal Value Of Each A And B Share​

* DECIDED TO REDUCE NOMINAL VALUE OF EACH A AND B SHARE FROM DKK 2.50 PER SHARE TO DKK 0.50 PER SHARE.

BRIEF-Ambu A/S says to issue up to 1.3 mln B shares in private placement

* Reg-Ambu A/S: Ambu A/S to issue up to 1,255,000 B shares in a private placement Source text for Eikon: Further company coverage: ( Bangalore.newsroom@thomsonreuters.com )

BRIEF-Ambu Q4 2016/17 EBIT up at DKK ‍134​ million

* Q4 2016/17 EBIT DKK 134 MILLION VERSUS DKK 131 MILLION YEAR AGO

BRIEF-Ambu buys Invendo Medical for EUR 225 million

* REG-AMBU ACQUIRES INVENDO MEDICAL AND ENTERS MARKET OF 70 MILLION GASTRO PROCEDURES ANNUALLY

BRIEF-Ambu plans to ‍generate an EBIT margin of 24-25 pct in 2020

* TOWARDS 2020 AMBU PLANS TO GROW ORGANICALLY BY 13-15% ANNUALLY AND EXPAND EBIT-MARGIN BY MORE THAN 5%-PTS

BRIEF-Ambu Q3 2016/17 EBIT up at DKK 130 million

* OUTLOOK IS NOW FOR ORGANIC GROWTH OF APPROX. 14% AGAINST PREVIOUSLY ANNOUNCED OUTLOOK OF 12-14%

BRIEF-Ambu Q2 2016/2017 EBIT DKK 121 million

* OUTLOOK IS NOW FOR ORGANIC GROWTH OF 12-14% AGAINST PREVIOUSLY ANNOUNCED OUTLOOK OF 9-11%

BRIEF-Adiuvo Investments unit terminates deal with Ambu

* Said on Wednesday that its unit, Airway Medix, terminates by mutual agreement distribution deal with Denmark-based Ambu A/S (Ambu)

BRIEF-Ambu Q1 EBIT up at DKK 65 million, FY outlook raised

* Q1 2016/17 revenue 512 million Danish crowns ($74.24 million) versus 462 million crowns year ago

BRIEF-Ambu Q4 EBIT up at DKK 131 million

* Q4 2015/16 revenue 573 million Danish crowns ($85.13 million) versus 536 million crowns year ago

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up